24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Bristol-Myers Squib
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:34
Intel reaches secret settlement in $1 million fraud lawsuit with ex-employee and supplier
14:41
AU10TIX founder steps aside as company overhauls leadership
14:22
Court ruling under scrutiny after AI-linked legal citations found to be inaccurate
11:31
The AI company worth more than Israel's GDP - what it means for us
More stories
Buzz
Most popular
Daily
Weekly
1
Israel’s new AI-powered artillery makes combat debut in Lebanon
2
Zim strike halts operations as takeover tensions escalate
3
Russia targets Ukraine’s drone supply chain, names Israeli company
4
Israeli startup unveils world’s first chocolate bars made with lab-grown cocoa butter
5
The AI cybersecurity boom may be creating a bigger problem than it solves
More news
Bristol-Myers Squib
2 stories about Bristol-Myers Squib
Immunai and Bristol Myers Squibb turn to AI to decode immune responses in clinical trials
15.01.26
|
CTech
The collaboration aims to improve understanding of patient biology in clinical trials.
Bristol-Myers Squibb Invests $12 Million in Israeli Immunotherapy Company Compugen
12.10.18
|
Dror Reich
The investment is part of a clinical trial collaboration for a treatment that combines Compugen’s investigational antibody with an immune checkpoint inhibitor from Bristol-Myers Squibb